Showing results (41-50 of 55) with videos related to

Sort By:
Pageof 6
Movement Disorders : Official Journal of the Movement Disorder Society|September 24, 1999
Choreic movements and MRI abnormalities in the subthalamic nuclei reversible after administration of coenzyme Q10 and multiple vitamins in a patient with bilateral optic neuropathyP Chariot, P Brugières, M C Eliezer-Vanerot, et al.
The American Journal of Medicine|March 1, 1991
Systemic mast cell disease associated with primary mediastinal germ cell tumorP Chariot, I Monnet, F LeLong, et al.
Human Pathology|January 1, 1993
Systemic mastocytosis following mediastinal germ cell tumor: an association confirmedP Chariot, I Monnet, P Gaulard, et al.
Journal of the Neurological Sciences|July 1, 1997
Cellular and mitochondrial toxicity of zidovudine (AZT), didanosine (ddI) and zalcitabine (ddC) on cultured human muscle cellsE Benbrik, P Chariot, S Bonavaud, et al.
Journal of Computer Assisted Tomography|October 19, 1999
MRI of intralesional hemolysis in focal nodular hyperplasia of the liverA E Mahfouz, A Rahmouni, C Terem, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 1, 1992
Extensive small-cell lung cancer. A randomized comparison of two chemotherapy programs with early crossover in instances of failure. Association pour le Traitement des Tumeurs Intra-Thoraciques (ATTIT)I Monnet, P Chariot, E Quoix, et al.
British Journal of Clinical Pharmacology|September 1, 1996
Lipid-lowering drugs and mitochondrial function: effects of HMG-CoA reductase inhibitors on serum ubiquinone and blood lactate/pyruvate ratioG De Pinieux, P Chariot, M Ammi-Saïd, et al.
Arthritis and Rheumatism|April 1, 1994
Determination of the blood lactate:pyruvate ratio as a noninvasive test for the diagnosis of zidovudine myopathyP Chariot, I Monnet, M Mouchet, et al.
Pageof 6